Litigation Challenges Prioritization of Race or Ethnicity in Allocating COVID-19 Therapies
Within a few weeks after the New York guidelines were issued, the federal lawsuits commenced.

The discrepancy between past booster messaging and the current, broad recommendation has spawned public health communications problems.

COVID-19 vaccine hesitancy is further exacerbated by waves of misinformation promulgated on social media.

Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.

The pandemic has laid bare the lack of regulation for the sharing of intellectual property needed for an effective and equitable response.

The COVID-19 pandemic has brought into sharp relief longstanding equity problems surrounding the allocation of newly developed vaccines.
